April 5 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday its sales revenue fell by an annual 3% in the first three months of 2018.
Domestic sales revenue edged up 0.5% year-on-year in the January-March period, while exports decreased 6%, the company said in a bourse filing.
In March alone, Sopharma's sales declined 10% year-on-year as exports fell 19%, while sales on the domestic market edged up 1%.
The company did not disclose information about the volume of its sales or amount of sales revenue.
As at 13:15 CET on Thursday, Sopharma shares traded flat at 4.24 levs ($2.7/2.2 euro).
(1 euro = 1.95583 levs)